vs
PagerDuty, Inc.（PD）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
PagerDuty, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.8倍（$124.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 129.7%，领先254.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 4.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 5.9%）
PagerDuty是一家美国云计算企业，主打面向IT运维部门的SaaS事件管理平台，可帮助企业实时响应运维异常、快速定位并处理故障，保障业务系统稳定运行，目前已成为全球IT运维领域广受认可的数字化解决方案服务商。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PD vs RIGL — 直观对比
营收规模更大
PD
是对方的1.8倍
$69.8M
营收增速更快
RIGL
高出16.5%
4.7%
净利率更高
RIGL
高出254.3%
129.7%
两年增速更快
RIGL
近两年复合增速
5.9%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $124.5M | $69.8M |
| 净利润 | $161.6M | $268.1M |
| 毛利率 | 85.3% | 91.5% |
| 营业利润率 | 6.5% | 33.2% |
| 净利率 | 129.7% | 384.0% |
| 营收同比 | 4.7% | 21.2% |
| 净利润同比 | 2827.7% | 1769.2% |
| 每股收益（稀释后） | $1.69 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PDRIGL
| Q4 25 | $124.5M | $69.8M | ||
| Q3 25 | $123.4M | $69.5M | ||
| Q2 25 | $119.8M | $101.7M | ||
| Q1 25 | $121.4M | $53.3M | ||
| Q4 24 | $118.9M | $57.6M | ||
| Q3 24 | $115.9M | $55.3M | ||
| Q2 24 | $111.2M | $36.8M | ||
| Q1 24 | $111.1M | $29.5M |
净利润PDRIGL
| Q4 25 | $161.6M | $268.1M | ||
| Q3 25 | $9.6M | $27.9M | ||
| Q2 25 | $-7.2M | $59.6M | ||
| Q1 25 | $-8.8M | $11.4M | ||
| Q4 24 | $-5.9M | $14.3M | ||
| Q3 24 | $-10.9M | $12.4M | ||
| Q2 24 | $-17.1M | $-1.0M | ||
| Q1 24 | $-28.2M | $-8.2M |
毛利率PDRIGL
| Q4 25 | 85.3% | 91.5% | ||
| Q3 25 | 84.6% | 93.2% | ||
| Q2 25 | 84.0% | 95.6% | ||
| Q1 25 | 83.6% | 91.7% | ||
| Q4 24 | 83.0% | 89.9% | ||
| Q3 24 | 82.7% | 85.5% | ||
| Q2 24 | 82.6% | 92.4% | ||
| Q1 24 | 81.7% | 93.1% |
营业利润率PDRIGL
| Q4 25 | 6.5% | 33.2% | ||
| Q3 25 | 2.9% | 40.9% | ||
| Q2 25 | -8.6% | 60.1% | ||
| Q1 25 | -9.6% | 23.9% | ||
| Q4 24 | -8.7% | 28.9% | ||
| Q3 24 | -13.8% | 25.4% | ||
| Q2 24 | -19.5% | 1.2% | ||
| Q1 24 | -30.1% | -23.6% |
净利率PDRIGL
| Q4 25 | 129.7% | 384.0% | ||
| Q3 25 | 7.8% | 40.2% | ||
| Q2 25 | -6.0% | 58.6% | ||
| Q1 25 | -7.2% | 21.5% | ||
| Q4 24 | -5.0% | 24.9% | ||
| Q3 24 | -9.4% | 22.5% | ||
| Q2 24 | -15.4% | -2.8% | ||
| Q1 24 | -25.3% | -27.9% |
每股收益（稀释后）PDRIGL
| Q4 25 | $1.69 | $14.11 | ||
| Q3 25 | $0.10 | $1.46 | ||
| Q2 25 | $-0.07 | $3.28 | ||
| Q1 25 | $-0.12 | $0.63 | ||
| Q4 24 | $-0.07 | $0.82 | ||
| Q3 24 | $-0.14 | $0.70 | ||
| Q2 24 | $-0.26 | $-0.06 | ||
| Q1 24 | $-0.34 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $547.8M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $320.5M | $391.5M |
| 总资产 | $1.0B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PDRIGL
| Q4 25 | $547.8M | $155.0M | ||
| Q3 25 | $567.9M | $137.1M | ||
| Q2 25 | $597.1M | $108.4M | ||
| Q1 25 | $570.8M | $77.1M | ||
| Q4 24 | $542.2M | $77.3M | ||
| Q3 24 | $599.3M | $61.1M | ||
| Q2 24 | $592.8M | $49.1M | ||
| Q1 24 | $571.2M | $49.5M |
总债务PDRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | $484.5M | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | $489.5M | $60.0M |
股东权益PDRIGL
| Q4 25 | $320.5M | $391.5M | ||
| Q3 25 | $180.7M | $117.6M | ||
| Q2 25 | $145.7M | $81.9M | ||
| Q1 25 | $129.8M | $18.6M | ||
| Q4 24 | $111.6M | $3.3M | ||
| Q3 24 | $164.7M | $-14.6M | ||
| Q2 24 | $174.0M | $-29.9M | ||
| Q1 24 | $171.6M | $-31.7M |
总资产PDRIGL
| Q4 25 | $1.0B | $513.6M | ||
| Q3 25 | $891.5M | $242.5M | ||
| Q2 25 | $926.8M | $206.7M | ||
| Q1 25 | $927.3M | $176.0M | ||
| Q4 24 | $866.8M | $164.0M | ||
| Q3 24 | $916.0M | $139.4M | ||
| Q2 24 | $924.0M | $128.4M | ||
| Q1 24 | $925.3M | $126.5M |
负债/权益比PDRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | 3.73× | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.85× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $24.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $24.1M | — |
| 自由现金流率自由现金流/营收 | 19.3% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | 0.15× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $117.6M | — |
8季度趋势，按日历期对齐
经营现金流PDRIGL
| Q4 25 | $24.8M | $22.0M | ||
| Q3 25 | $34.0M | $24.0M | ||
| Q2 25 | $30.7M | $30.5M | ||
| Q1 25 | $31.4M | $-893.0K | ||
| Q4 24 | $22.1M | $14.5M | ||
| Q3 24 | $35.8M | $21.7M | ||
| Q2 24 | $28.6M | $302.0K | ||
| Q1 24 | $22.2M | $-5.0M |
自由现金流PDRIGL
| Q4 25 | $24.1M | — | ||
| Q3 25 | $33.1M | — | ||
| Q2 25 | $30.2M | — | ||
| Q1 25 | $30.3M | — | ||
| Q4 24 | $21.5M | — | ||
| Q3 24 | $35.1M | — | ||
| Q2 24 | $28.2M | — | ||
| Q1 24 | $21.2M | — |
自由现金流率PDRIGL
| Q4 25 | 19.3% | — | ||
| Q3 25 | 26.8% | — | ||
| Q2 25 | 25.2% | — | ||
| Q1 25 | 24.9% | — | ||
| Q4 24 | 18.1% | — | ||
| Q3 24 | 30.3% | — | ||
| Q2 24 | 25.4% | — | ||
| Q1 24 | 19.1% | — |
资本支出强度PDRIGL
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.9% | — |
现金转化率PDRIGL
| Q4 25 | 0.15× | 0.08× | ||
| Q3 25 | 3.55× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
RIGL
暂无分部数据
